Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants
Pediatric research 86.6 (2019): 749-757
Henrick, Bethany M., et al.
Analysis of fecal samples of a subset of infants from a randomized open label trial to determine the effects of supplementing the probiotic Bifidobacterium longum subsp. infantis for the first 21 days finds 40d old control infants exhibit chronic enteric inflammation, which is significantly different from infants colonized with B. infantis EVC001.
Related content in Publications
Frontiers in Nutrition 7 (2020): 33
Integrating the ecosystem services framework to define dysbiosis of the breastfed infant gut: the ro...Read more
FEMS Microbiology Letters 367.6 (2020): fnaa032
Reintroducing B. infantis to the cesarean‐born neonate: an ecologically sound alternative...Read more
Scientific Reports 11.1 (2021): 1472
Metagenomic insights of the infant microbiome community structure and function across multiple sites...Read more
Pediatric research 77.1 (2015): 229-235